COVID-19, the infectious disease caused by SARS-CoV-2, has spread on a pandemic scale.
The viral infection can evolve asymptomatically or can generate severe symptoms …

The dysregulation of both the innate and adaptive responses to SARS-CoV-2 have an
impact on the course of COVID-19, and play a role in the clinical outcome of the disease …

Abstract COVID-19 is associated with 5.1% mortality. Although the virological,
epidemiological, clinical, and management outcome features of COVID-19 patients have …

COVID-19 manifests with a wide diversity of clinical phenotypes characterized by
dysfunctional and exaggerated host immune responses. Many results have been described …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces a T cell
response that most likely contributes to virus control in COVID-19 patients but may also …

BackgroundThe role of cellular immunity in pathogenesis of COVID-19 is unclear and
conflicting data points to insufficient or pathogenic immunity as drivers of COVID-19 …

The spectrum of coronavirus disease 2019 (COVID-19) severity, related to cellular immune
functions, has not been fully clarified yet. Therefore, this study aimed to investigate the …

Abstract Background Coronavirus disease 2019 (COVID-19) is a respiratory disorder
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which had …

Abstract Aims Coronavirus disease 2019 (COVID-19) is a novel viral infection threatening
worldwide health as currently there exists no effective treatment strategy and vaccination …

Background: The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed great threat to human health …